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Functional basis for the glomerular alterations in uranyl nitrate acute
renal failure. We have examined the acute renal failure that occurs after
uranyl nitrate administration in the rat and the specific effects of
pretreatment of rats with angiotensin converting enzyme inhibitor
(CE!), plasma volume expansion (PVE) after uranyl nitrate, and a
combination of these treatments. We utilized a combination of micro-
puncture measurements of glomerular hemodynamics, cage studies,
and histologic examination of renal tissue to evaluate the degree of
acute renal failure in all groups studied. Uranyl nitrate (UN) (25 mg/kg
body wt) administration caused a reduction in the nephron filtration rate
(SNGFR) (39.4 1.6 to 24.8 2.9 nl min g kidney wt, P < 0.02)
as a result of a major decrease in the glomerular ultrafiltration coeffi-
cient (LpA) from control values ( 0.085 0.008 to 0.035 0.007 n1
secT mm Hg g kidney wt, P <0.01). Treatments with CE!, PVE,
and the combination of CE! and PVE in rats receiving UN restored
LpA to normal values (> 0.061 0.009, 0.091 0.020, and 0.138
0.020 nl sec mm Hg g kidney wt, respectively). Cage studies
revealed that CE! treatment prevented oliguria and resulted in major
volume losses and reduction in weight. However, rats died after a
similar period after UN, but probably by different mechanisms. Anal-
ysis of renal ultrastructure revealed equivalent tubular damage in all
experimental groups. Alterations in LpA after UN are functional in
nature and are potentially preventable and reversible by a combination
of treatments with CE! and PVE.
Base fonctionnelle des alterations glomerulaires au cours de l'insuffis-
ance rénale aigue par nitrate d'uranyl. Nous avons examine l'insuffis-
ance rénale aigue qui survient aprés administration de nitrate d'uranyl
chez Ic rat et les effets spécifiques du pré-traitement des rats par un
inhibiteur de l'enzyme de conversion (CE!), par une expansion du
volume plasmatique (PVE) aprés Ic nitrate d'uranyl, et par l'association
de ces traitements. Nous avons utilisé une combinaison de mesures par
microponction de l'hCmodynamique glomérulaire, d'études en cage, et
d'examen histologique des tissus rénaux afin d'évaluer Ic degré d'insuf-
fisance rénale aigue dans tous les groupes étudiés. L'administration de
nitrate d'uranyl (UN) (25 mg/kg poids corp) a rCduit le debit de filtration
néphronique (SNGFR) (39,4 1,6 a 24,8 2,9 nl min g rein
poids1, P < 0.02), consequence d'une diminution importante du
coefficient d'ultrafiltration glomérulaire (LpA) des valeurs contrôles (
0,085 0,008 a 0,035 0,007 nI sec' mm Hg' g rein poids', P
< 0.01). Les traitements par CE!, PVE, ou l'association CE! et PVE
chez les rats recevant UN a restauré LpA a des valeurs normales (>
0,061 0,009, 0,091 0,020, et 0,138 0,020 nI sec' mm Hg g
reins poids, respectivement). Les etudes en cage ont révélé que Ic
traitement par CEI empéchait l'oligurie ci aboutissait a des pertes
Received for publication December 12, 1984,
and in revised form March 29, 1985
© 1985 by the !nternational Society of Nephrology
importantes de volume et A une reduction du poids. Cependant, les rats
mourraient aprés une periode identique après UN, mais probablement
par des mécanismes diffCrents. L'analyse de l'ultrastructure rénale a
révélC des alterations tubulaires equivalentes dans bus les groupes
expérimentaux. Les alterations de LpA aprés UN soft de nature
fonctionnelle et sont potentiellement prévenues et réversibles par une
association de traitement avec CE! ci PVE.
In 1975, micropuncture studies from our laboratory revealed
that the reduction in kidney glomerular filtration rate that
occurs within a few hours after the administration of either 15 or
25 mg/kg body wt uranyl nitrate (i.v.) was the result of two renal
events: 1) significant transepithelial backleak of solutes as large
as inulin across damaged tubules beyond the mid-proximal
tubule; and 2) a major reduction in the glomerular ultrafiltration
coefficient (LpA), the product of glomerular hydraulic conduc-
tance (Lp), and ultrafiltering surface area (A) [1]. These studies
represented the first direct and quantitative demonstration of a
reduction in LpA in an experimental model of acute renal
failure. Separate but parallel studies during the past decade
have also demonstrated that naturally occurring hormonal
substances can lead to reductions in LpA [2]. In 1976, our
laboratory examined the effects of intravenous angiotensin II
and found that in addition to the well-documented increase in
renal vascular resistances, angiotensin II produced a major
reduction in the glomerular ultrafiltration coefficient by influ-
encing either or both capillary hydraulic conductance and
glomerular surface area [3]. Certain altered physiologic states
have been associated with reductions in LpA, and there is
reasonable evidence that angiotensin II may be involved in this
process [2]. A specific morphologic and mechanical explanation
for the action of angiotensin in affecting LpA has not been
delineated. However, studies have demonstrated angiotensin II
receptors within glomeruli [4], and glomerular mesangial cells in
culture do respond to angiotensin II by contracting [5]. A
variety of studies also suggest that angiotensin II effects upon
LpA are readily reversible and not dependent upon permanent
architectural alterations [6—8].
The basic hypotheses to be tested in the current study are: 1)
the decrease in LpA that occurs after uranyl nitrate administra-
tion is functional in origin, and 2) the LpA effects in this model
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of acute renal failure may be either preventable or reversible
with treatments such as converting enzyme inhibition and
plasma volume expansion, maneuvers which reduce the intra-
renal generation of angiotensin II [9, 10].
Methods
Studies were performed with male Munich-Wistar rats (190 to
290 g), bred and maintained in a colony housed at the Animal
Research Facility, Veterans Administration Medical Center,
San Diego, California, USA. Animals were fed standard rodent
chow (#5001, Ralston Purina Company, St. Louis, Missouri,
USA) until 16 hrs prior to micropuncture, but were permitted
free access to water. Rats were anesthetized with mactin (100
mg/kg body wt, i.p.) Surgical preparation was as described
previously [3, 11, 12]. All maintenance infusions were admin-
istered via a jugular vein catheter (P.E. 50). In all groups, a
separate infusion of 14C inulin ( 40 Ci/hr) dissolved in
isotonic sodium chloride and sodium bicarbonate (0.5% to 0.7%
body wt/hr) was begun 1 hr prior to the measurement period.
Hydropenic groups
Four groups of hydropenic rats were studied; all received a
total infusion rate of 0.5 to 0.7% body wt prior to and through-
out micropuncture measurements. Hydropenic control rats (N
= 15) received maintenance infusion and no pretreatment or
other infusions. Measurements of glomerular capillary (PG) and
Bowman's space (PBS), as well as peritubular capillary hydro-
static pressures (HPE), were performed with a servo-nulling
device using 1 to 2 jsm tip pipets. Methods of pressure mea-
surement and the mechanics of the pressure monitoring device
have been described in previous publications from this labora-
tory [3, 11, 131. Samples of tubular fluid were collected from
early segments of proximal tubules for measurement of single
nephron glomerular filtration rate (SNGFR). At least three
samples of efferent peritubular capillary blood from "star"
vessels were obtained for measurement of protein concentra-
tion. Mean arterial blood pressure (MAP), whole kidney
glomerular filtration rate (GFR), and hematocrit (HCT) were
measured throughout the period.
In a second group, hydropenic rats (N = 7) were pretreated
with uranyl nitrate (UN) 90 mm prior to micropuncture surgery.
The UN was administered via a subcutaneous (SQ) injection in
the back using a dose of 25 mg UN/kg body wt, All other
measurements followed the protocol for hydropenic control
rats.
The third hydropenic micropuncture group used (N = 6) was
constituted by rats pretreated 2 to 4 days with CEI (converting
enzyme inhibitor) drinking water (33 mg captopriLlloo ml H20,
SQ14,225, Squibb & Sons, Princeton, New Jersey, USA) ad
libitum. These rats were deprived of food for 16 hrs prior to
surgery. Rats were infused with 1 mg CEI/ml in isotonic sodium
chloride and sodium bicarbonate solution (1 mg captopril/kg
body wt/hr) initiated within 20 to 30 mm after anesthesia. The
inulin infusion rate and concentration were adjusted to guaran-
tee that the rat received the same total volume as supplied to
rats in the other two hydropenic groups (0.5% to 0.7% body
wt/hr). All other aspects of the protocol were identical to the
hydropenic control group.
Another group of six hydropenic rats were submitted to CEI
treatment using the same protocol, but received no UN. The
single effect of CEI upon SNGFR and the determinants thereof
were assessed in this group using identical micropuncture
techniques.
Three groups of seven hydropenic rats were maintained in
metabolic cages with free access to standard rodent chow and
water. One group served as a normal control. The next two
groups received 25 mg/kg body wt UN subcutaneously to
reproduce the dose and mode of administration used in the
micropuncture studies. One of these UN groups received oral
CEI in drinking water from 2 days prior to UN injection until 7
days after or time of death. Daily weights and urine outputs
were monitored in each group and recorded.
Plasma volume expansion groups
In three groups, a plasma volume expansion (PVE) protocol
was utilized using 2.5% body wt littermate plasma and 1.25%
body wt isotonic sodium chloride and sodium bicarbonate
solution infused over 1 hr [3, 13]. The plasma infusion was
followed by additional saline-bicarbonate solution at a rate 20
dJmin in excess of total urine flow rate to maintain the volume
status. Standard inulin infusion of 40 tCiIhr (0.5 to 0.7%
body wt/hr) was begun at the initiation of PVE and continued
throughout the measurement period in the PVE control group
(N 10). All measurements were identical to those obtained in
the hydropenic control group. A second group (N = 6) followed
the same protocol as in PVE control group, but was pretreated
with UN 3 hrs prior to PVE. Ninety mm prior to surgical
preparation, each rat was injected with 25 mg UN/kg body wt
subcutaneously. All micropuncture measurements were ob-
tained in this UN-PVE group as in the hydropenic control
group.
The third PVE group utilized rats pretreated 2 to 4 days with
CEI water (N = 6). Rats were injected subcutaneously with UN
(25 mg/kg body wt) 90 mm prior to surgery with continued free
access to CEI water. An infusion of CEI (1 mg captopril/mi
saline-bicarb/kg body wtlhr) was begun 20 to 30 mm after
anesthesia. The plasma expansion protocol commenced with
the concurrent administration of CEI and inulin. The inulin
volume and concentration were adjusted to deliver the same
radioisotope level per hr while compensating for the CEI
infusion volume. All other aspects of the protocol for this
UN-PVE-CEI group were identical to the hydropenic control
group.
Micropuncture measurements
At least four to six measurements of nephron filtration rate
(SNGFR) were obtained from each rat. Samples were collected
from early to midportions of surface proximal tubules to avoid
underestimation of SNGFR, since much of tubular damage and
a presumed region of tubular 'backleak" of inulin has been
noted in later portions of the proximal tubule [1, 14, 15]. After
insertion of a small mineral oil block (3 to 4 tubule diameters)
via a 8 to 11 m tip glass pipet, the collections were spontane-
ous throughout the time period. Care was taken to prevent
alterations in tubular diameter during the collection.
In all groups, total urine volume was collected in preweighed
containers under oil. From the radioactivity in both urine and
plasma samples, the total kidney inulin clearance (C1) was
determined for right and left (micropuncture) kidneys.
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Earlier studies demonstrated that little or no inulin "back-
leak" occurred within the accessible proximal tubule after UN
administration since SNGFR obtained in early proximal seg-
ments did not differ from those obtained from late proximal
tubular collections. To validate the quantitative accuracy of
SNGFR collections after UN, further studies were conducted.
Hydropenic rats were utilized that received UN 90 mm prior to
micropuncture surgery. 3H inulin was added to isotonic NaCl-
NaHCO3 solutions to achieve count rates of - 14 cpm/nl of
solution. Utilizing a Hampel microperfusion pump, this solution
was added to the normal flow in early proximal tubular seg-
ments and timed collections obtained from the last accessible
proximal segment. Control perfusions were conducted into H20
containing vials to determine 100% recovery rates of inulin.
Control perfusions were interspersed with tubule perfusions
and data expressed as inulin recovery as a percentage of control
perfusion inulin values.
Analytic methods
Nephron filtration rate (SNGFR) was calculated from the
total counts of ['4C] inulin in tubular fluid sample divided by the
plasma counts per nanoliter and the time of the collection.
Specifics of the microprotein method have been described in
detail in prior publications [11, 12]. Plasma and urine electro-
lytes were determined on a flame photometer (Instrumentation
Laboratory, Inc., Lexington, Massachusetts, USA).
Calculations
The nephron plasma flow (SNPF) is calculated as follows:
SNPF = SNGFRJ(1 — CA/CE)
where CA is the systemic protein concentration, CE is the
efferent peritubular capillary protein concentration as deter-
mined by microprotein methods and (1 — CA/CE) = thenephron
filtration fraction (SNFF = SNGFRJSNPF). The nephron blood
flow (SNBF) is computed as described [3]. Afferent arteriolar
resistance (AR) is defined as
AR = (MAP — P0)ISNBF
where MAP mean arterial blood pressure and P0 = glomer-
ular capillary hydrostatic pressure, measured directly in mm
Hg. Efferent arteriolar resistance (ER) is defined by the
relationship
ER = (PG — HPE)/(SNBF — SNGFR)
where HPE is large efferent peritubular capillary hydrostatic
pressure.
The determinants of SNGFR are defined as follows:
SNGFR = LpA EFP
where mean effective filtration pressure = EFP along the
glomerular capillary length (x*) (where x* = x/l and 1 =
capillary length) is described as follows:
EFP* = (AP —
where ir = oncotic pressure (mm Hg), which is related to C
(gmIlOO ml) as follows:
= 1.76C + 0.28C2 [1, 12, 161
a simplification of the empirical relationship described by
Landis and Pappenheimer [17].
The EFP is defined as follows:
= of' (iP — lr)dx*
The EFP* curve and LpA are determined by an iterative
method as described previously from this laboratory [11, 12].
Morphologic studies
In a separate group of rats, tissues were taken for morpho-
logic analysis. The surgical protocol, infusions, and time course
were identical to the micropuncture groups described previ-
ously, but without '4C inulin administration. At the conclusion
of each experiment, a 2.5% glutaraldehyde in 0.075 M sodium
cacodylate-HC1 buffered fixative solution was infused via a P.E.
160 catheter inserted in the aorta just distal to the left renal
artery. The aorta was clamped above the renal arteries before
fixation and the kidney was then briefly flushed with 3 to 5 ml of
isotonic sodium chloride-sodium bicarbonate solution to clear
the kidneys of blood cells. Both renal veins were clipped while
flushing with the isotonic solution, then the fixative was infused
via the same catheter through a three-way teflon valve. The
infusion pressure was monitored throughout the fixation (80 mm
Hg) with a perfusion of 8 to 10 mllmin for 4 to 5 mm. After 30
to 40 ml of fixative was infused, the kidneys were removed,
bisected, and immediately placed in small vials of fixative. The
vials were coded randomly in a single-blind protocol and sent to
one of the authors' laboratories for morphologic analysis
(A.P.E.). Tissues remained in the fixative for 2 to 4 days.
After in situ tissue fixation, portions of the entire cortex of
the kidney were removed and further fixed in the original
fixative for a minimum of an additional 48 hrs. Subsequently,
the tissue was prepared for and quantitated by light microscopy
and transmission electron microscopy as described previously
[13, 18]. All renal samples were assigned numbers and read
without knowledge of the experimental regimens.
Light microscopic examination was performed on tissue that
was routinely dehydrated and embedded in JB-4 media
(Polysciences, Inc., Warrington, Pennsylvania, USA). The
tissue was sectioned at 4 m with a JB-4 microtome (DuPont-
Sorvall, Inc., Newton, Connecticut, USA) and stained with
toulidine blue. The sections were viewed on a Leitz laborlux 12
microscope with a 40 x objective and 10 x eyepiece (Midland,
Ontario, Canada).
Morphological changes in the nephrons of the different ex-
perimental groups were determined by a semiquantitative his-
tologic analysis [19, 20]. For each of the proximal, distal, and
cortical collecting tubular segments, we examined 50 individual
tubular cross sections per animal and scored the severity and
distribution of the lesions by the following scale: 0 = absence of
the lesion; 1 = lesion represented in less than 10% of the tubules
and with minimal injury; 2 = lesion represented in up to 25% of
the tubules and with moderate injury; 3 = lesion represented in
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Table 1. Glomerular hemodynamics in control rats, rats receiving uranyl nitrate (25 mg/kg body wt), and rats receiving uranyl nitrate and
treatments with converting enzyme inhibitor (CEI) and plasma volume expansion
Group
MAP PG PBS HPE mlmzn •g
kidney wr'mm Hg
Hydropenia (N = 15) 115°
2
47.5°
0.7
13.8°
0.5
33.7°
0.4
19.3a
0.5
1.12°
0.04
Hydropenia, uranyl 107b 51.1 10.8 40•3b 16.6 0•56b
nitrate pretreatment (N = 7) 3 1.9 1.8 1.6 3.7 0.14
Hydropenia, uranyl nitrate and CEI pretreat- 83 45.8 10.8 35.0 104b 0,38b
ment (N = 6) 2 2.6 1.6 1.8 1.9 0.07
Plasma volume expansion (N = 10) 125"°
2
585
0.9
209b
0.6
376b
0.6
227b
0.9
151bc
0.05
Plasma volume expansion, uranyl nitrate pre- 115 53.4 15.6 37,8b 221b 082b
treatment (N = 6) 6 2.5 1.4 1.5 1.0 0.05
Plasma volume expansion, uranyl nitrate and 105 58.3 23.1" 35.2 25.8t 1.05c
CEI pretreatment (N 6) 5 3.4 2.0 1.8 2.0 0.10
a Values are expressed as the mean of the average values derived for each animal SEM, N refers to number of animals studied.
b Significantly different from the control value (P < 0.02).
Significantly different from the uranyl nitrate value (P < 0.05).
d At filtration pressure equilibrium (P ITE), therefore, a minimum estimate, '.
25 to 50% of tubules with moderate injury; 4 lesion on 50 to
90% of the tubules with moderate injury; and 5 = lesion
represented in over 50% of the tubules and with severe injury.
Minimal injury was defined as a loss of the brush border and
amorphous debris in tubular lumen while moderate injury
included cell swelling and vacuolization. Severe injury was
noted by a loss of epithelial cells from tubular wall. Five
animals were examined from each experimental group.
For transmission electron microscopy, small pieces (1 mm
cubes) of cortical tissue were postfixed in 1% 0s04 in 0.075 M
cacodylate-HC1 buffer for 1 V2 hrs, rinsed in the cacodylate
buffer, and dehydrated through a series of graded ethanols.
Subsequently, the tissue was passed through two changes of
propylene oxide, embedded in Epon 812, and cured at 60°C for
24 to 48 hrs. Sections were cut at 60 to 90 nm on an LKB
ultramicrotome III (LKB Instruments, Inc., Rockville, Mary-
land, USA) with a diamond knife and stained with uranyl
acetate and lead citrate. The tissue was examined and photo-
graphed with a Phillips EM 400 Electron Microscope (Phillips
Electronic Instruments, Inc., Mahwah, New Jersey, USA).
Statistical analysis
Statistical analysis of physiologic data utilized analysis of
variance and unpaired analysis where appropriate as described
previously [11, 13, 21].
Results
The administration of uranyl nitrate did not alter the appear-
ance of the kidney surface in either hydropenic rats or those
rats which had undergone plasma volume expansion after
uranyl nitrate. As noted in a prior publication [1], uranyl nitrate
administration was associated with a modest initial increase in
urine volume, however, at the time of micropuncture (3 to 4 hrs
post injection), urine volumes did not differ significantly from
the untreated hydropenic control rats (1.7 0.1 4/mm in
control, 2.3 0.7 dImin with UN in hydropenia, and 2.0 0.4
tlImin with UN + CEI in hydropenia). Urine flow was in-
creased in plasma volume expansion + UN (29.4 5.2 d/min,
P < 0.05), and CEI + plasma volume expansion after UN (34.8
8.4 4/mm, P < 0.05) when compared to control plasma
volume expansion (7.2 0.6 j.d/min), possibly as a result of UN
induced tubular damage.
Studies in the hydropenic rat
Uranyl nitrate administration to hydropenic rats resulted in a
significant decrease in SNGFR to 24.8 2.9 n1 min' g kidney
wt1 compared to 39.4 1.6 nl• min' g kidney wtt in normal
hydropenic controls (P < 0.01) (Table 1). This decrease in
SNGFR was accompanied by an even greater decrease in C1
from 1.12 0.04 to 0.56 0.14 m1 min' g kidney wt' (P <
0.01), the greater reduction in C1 undoubtedly the result of
transepithelial backleak of inulin beyond the mid-proximal
tubule, as demonstrated previously in this experimental model
of acute renal failure [1]. The reduction in SNGFR was, in
major part, the consequence of a decrease in LpA from a
minimum estimate of 0.085 0.008 nl sec' mm Hg g
kidney wt' in control hydropenic rats at filtration pressure
equilibrium to 0.035 0.007 nl sec' mm Hg g kidney wF'
after uranyl nitrate administration (P < 0.01) (Table 1). Filtra-
tion pressure equilibrium was not attained in hydropenic rats
that received uranyl nitrate. The nephron plasma flow was also
somewhat decreased when compared to control hydropenic
levels. AR was, however, unchanged by UN administration,
but ER numerically increased from 11.8 1.2 to 16.8 2.3
dyne sec cm5 X iO (0.1 > P > 0.05). MAP was significantly
but modestly decreased after UN (115 2 vs. 107 3 mm Hg,
P < 0.05), which contributed to the decrease in SNPF (Table 1).
The glomerular capillary hydrostatic pressure gradient (AP)
actually increased after uranyl nitrate (33.7 0.4 vs. 40.3 1.6
mm Hg, P < 0.01), which counteracted a portion of the negative
effects of decreased LpA upon the SNGFR after UN. In
summary, UN decreased SNGFR primarily through a major
reduction in LpA. This influence of decreased LpA upon
SNGFR was therefore partially attenuated by the concomitant
increase in AP.
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Table 1. Continued
SNGFR SNPF SNBF SNFF 7'E
mm Hg
AR ER
xlO dyne•
sec cm5
EFPA EFPE js LpAnlsec gksdney
wr mm Hg_Inlmin'g kidney wr' mm Hg
394a 117a 271a 0.35° 16.9° 32.9° 22.2° 11,8° 16.6a 0.8° 8.0 0085ad
±1.6 ±8 ±19 ±0.01 ±0.4 ±1.0 ±1.8 ±1.2 ±0.5 ±1.0 ±0.6 ±0.008
24.8" 88b 202b 028" 19.2 31.9 22.9 16.8 21.2 8,5 15.3 0035b
±2.9 ±10 ±23 ±0.01 ±0.8 ±1.8 ±2.3 ±2.3 ±2.3 ±3.1 ±2.9 ±0.007
24.3" 74" 168b 0.34 20.0 38.1 18.3 20.6 15.0 —3.2 7.1 0061Cd
±1.9 ±8 ±19 ±0.03 ±1.0 ±2.6 ±1.8 ±1.9 ±2.0 ±3.9 ±2.5 ±0.009
63.7 264bc 461bc 025b 22.2 347 124bc 8.0c 15.4 2.9 8.6 0,128bc
±3.4 ±26 ±43 ±0.02 ±0.6 ±1.2 ±1.4 ±1.2 ±0.8 ±0.8 ±0.6 ±0.010
373C 174bc 297' 023" 22.8 34.8 17.4 11.4c 15.0 3.0 8.4 0091cd
±1.8 ±16 ±33 ±0.03 ±0.9 ±5.1 ±2.4 ±1.7 ±1.5 ±2.4 ±1.9 ±0.020
46.0" 212bc 396"" 0.23"' 23.2 34.8 101bc 77bc 12.0 0.4 6.0 Q,138bcd
±2.4 ±25 ±44 ±0.02 ±1.0 ±1.9 ±1.8 ±0.8 ±1.1 ±2.2 ±1.3 ±0.020
ItX I
Fig. 1. A comparison of values for the glomerular ultrafiltration
coefficient in each of the control and experimental groups. Groups in
which filtration pressure equilibrium was attained (zP it E) are
designated by the symbol (X), and the values for LpA are minimum
possible values. In the remaining groups, filtration pressure equilibrium
was not attained and the values for LpA are exact values. The symbol
(t) designates those treatment groups in which LpA was significantly
increased above values in rats receiving uranyl nitrate alone. Uranyl
nitrate, therefore, decreases LpA and treatments with CEL and PVE
restores LpA to at least control values.
Table 2 demonstrates data on the effects of CEI alone in both
hydropenic rats and rats which have undergone plasma volume
expansion (PVE). In hydropenic rats, CEI causes a reduction in
MAP, yet SNGFR is reasonably well maintained. CEI does not
specifically increase LpA. In fact, there is a tendency in
hydropenic rats with intact renal innervation for LpA to de-
crease slightly after CE! administration [7, 22]. The mechanism
of this apparent small decrease in LpA in innervated
hydropenic rats remains to be elucidated. It is clear that CE!
administration does not produce a non-specific increase in LpA
in the normal rat.
Pretreatment with CEI exerted several major effects upon
glomerular function in rats receiving UN. The combination of
CEI pretreatment and UN administration resulted in a further
and major decrease in MAP to 83 ± 2 mm Hg (P < 0.01), values
also significantly lower than UN rats. C1 (0.38 ± 0.07 ml/min,
P < 0.01) and SNGFR were also decreased below control
values in UN rats receiving CEI. The persistent reduction in
SNGFR was due to a continued low value for SNPF (74 ± 8 nl
• min' g kidney wr', P <0.01) and a lesser value for zIP than
observed in UN rats (35.0 ± 1.8 mm Hg). The major continued
reduction in C1, was undoubtedly largely the result of persistent
"backleak" of inulin across damaged tubules beyond the prox-
imal tubule [1]. These rats, in contrast to rats receiving UN
alone, attained filtration pressure equilibrium for at least two
reasons: the continued lower SNPF due to the reduction in
MAP, and an increase in LpA (minimum estimate) to 0.061 ±
0.009 n1 sec' mm Hg1 g kidney wt (P < 0.05) compared
to UN rats, NS compared to control hydropenic values (Fig. 1).
CEI pretreatment prevented the UN reduction in LpA but did
not restore SNGFR to normal because of the reduced values for
SNPF, secondary to further reductions of MAP, and the lesser
value for zIP when compared to the elevated values in UN rats.
Continued tubular "backleak" also contributed to the persist-
ent reduction in C1 as evidenced by the greater percentage
reduction in GFR than SNGFR.
Twenty-five mg UN/kg body wt was given to two groups of
awake rats (N = 7): 1) rats receiving UN alone; and 2) rats
injected with UN on continuous CEI drinking water (N = 7);
and a control group that received neither UN nor CEI (N = 7).
Four of the seven UN rats became oliguric after 2 days. None
of the rats treated with CEI became oliguric, in fact, urine
volume was normal to high for the first 4 to 5 days. In spite of
the maintenance of urine output in the CEI treated rats,
mortality was 100% within 7 days, whereas only three of seven
UN rats died within this period. This finding may be explained
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Table 2. Effect of converting enzyme inhibitor (CE!) administration on the determinants of nephron ifitration rate in normal hydropenic and
plasma volume expanded (PVE) rats
LpA
MAP
mm Hg
SNGFR SNPF P A n1 sec' gkidney wr'
n! min' g kidney wr' mm Hg mm Hg1
Hydropenic control rats
(N = 15) 115 2 39.4 1.6 117 8 33.7 0.4 16.9 0.4 32.9 1.0 0.08a 0.01
Hydropenic rats pretreated
with CE! for 48 hr(N 6) 88 5 37.6 3.5 115 21 34.2 1.5 13.5 0.5 27.1 0.5 0.05 0.004
Hydropenic ratsb pretreated
with CE! for 14 days(N 6) 72 5 29.8 5.8 141 30 30.6 2.6 17.2 1.4 24.8 1.5 0.07 0.02
Hydropenic ratsc with acute
CE! infusion (N = 6) 93 1 34.5 1,2 107 4 34.6 0.7 16.7 0.9 30.6 1.0 0.05 0.03
PVE control rats (N = 10) 125 2 63.7 3.4 264 26 37.6 0.6 22.2 0.6 34.7 1.2 0.13 0.01
PVE after CE! pretreatment
(N = 6) 111 3 55.8 1.8 198 16 39.7 0.9 20.9 0.5 35.7 1.1 0.10 0.02
a Filtration pressure equilibrium.
b From [36].
From [7].
by differences in volume status, as reflected by changes in body
wt. In rats receiving UN alone, body wt decreased by —4.1
1.9% by 7 days or time of death, compared to a —0.6 2.0%
change in untreated control rats. However, rats that received
UN and treatment with CEI incurred a decrease in body wt of
—17.6 1.7%, values significantly greater than either control or
UN rats (P < 0.01). These results demonstrate that chronic CEI
treatment does not prevent death from UN-induced acute renal
failure, in spite of the early beneficial effects of CEI treatment.
However, the mechanisms producing death may differ in that
the combination of UN administration and CE! treatment leads
to greater degrees of volume depletion, possibly by maintaining
a higher initial GFR in the setting of continued tubular damage.
Studies in rats submitted to plasma volume expansion
Values for SNGFR, C1, and all of the pertinent pressures,
flows, and resistances in control plasma volume expanded rats,
rats undergoing plasma volume expansion (PVE) within 3 to 4
hours after UN administration, and rats pretreated with CEI,
which received UN and were later submitted to PVE (UN-
PVE+CEI), also appear in Table 1.
In rats that received UN and were submitted to PVE,
SNGFR increased to values not different from hydropenic
untreated controls (37.3 1.8 vs. 39.4 1.6 ni min g kidney
wr'), but significantly higher than rats receiving UN alone
(24.8 2.9 n1 min' g kidney wt', P < 0.01). However, C1
remained lower than untreated hydropenic control rats, (0.82
0.05 vs. 1.12 0.04 ml min' g kidney wr'), in rats
undergoing PVE after UN administration, probably as a result
of continued "backleak" of inulin across damaged epithelia
beyond the proximal tubule in rats receiving UN. Post-UN PVE
restored SNGFR to the normal untreated values by at least two
mechanisms: 1) the SNPF increased to 174 16 nl min1 g
kidney wr1, values significantly higher than both untreated
controls (P < 0.02) and rats receiving UN (P < 0.01); and 2) a
major increase in LpA to 0.091 0.020 nl sec mm Hg1
g kidney wr', values higher than in rats receiving UN (0.035
0.007 n1 sec mm Hg1, P <0.01) and equal to values in
untreated control rats (0.085 0.008 nI . sec' mm Hg' g
kidney wtt, NS) (Fig. 1). P was not significantly different
from UN treated rats. Therefore, PVE within 3 to 4 hours after
UN also restored LpA to values not different from normal
control, an effect also observed with CEI pretreatment alone.
Data depicted in Table 2 demonstrates that CE! does not
further increase the LpA in rats submitted to PVE. Also, other
determinants of SNGFR are not significantly influenced by CEI
in normal rats after PVE. The combination of CE! pretreatment
and PVE after UN administration resulted in an even higher
value for SNGFR (46.0 2.4 nl . min' g kidney wt', P <
0.01 compared to untreated control rats), but these values
remained lower than untreated PVE control rats (63.7 3.4 nl
g kidney wt', P < 0.01). C was 1.05 0.10 m1
min' g kidney wt in this group, a value similar to the
hydropenic, untreated rats, but significantly lower than PVE
control rats that did not receive UN (1.51 0.05 ml min' g
kidney wr', P < 0.01). LpA was again increased to values
much higher than in rats receiving UN only (0.138 0.020 nl
sec1 mm Hg . kidney wrt), but values not significantly
different from rats undergoing PVE after UN (both "normal"
values) (Table 1). The reason that SNGFR in CE! pretreated
rats receiving UN and undergoing PVE remained lower than
untreated PVE control rats was a lesser value for SNPF. This
decrease in SNPF was the result of a significantly lower value
for MAP rather than a result of any differences in either afferent
or efferent arteriolar resistance.
Both plasma volume expansion after UN administration and
PVE plus CEI pretreatment resulted in an increase in LpA to
normal values in rats that had received UN. SNGFR and SNPF
were also increased to values equal to or greater than untreated
hydropenic control rats (Table 1). C1, tended to remain lower in
rats that received UN, undoubtedly as a result of continued
transepithelial "backleak" of inulin.
Inulin recovery was utilized as an index of transepithelial
"backleak" after UN in this study. In 19 tubules in the
hydropenic condition after UN, the mean recovery of inulin
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Fig. 2. Light micrographs of the cortex from a control rat (A), animal that
received uranyl nitrate 90 mm prior to micropuncture (B), and rats that
received uranyl nitrate treatment with both GEl and plasma volume
expansion (C). In the control rat, normal proximal (P) and distal (D) tubules
are seen. The animals that received uranyl nitrate possess proximal (P)
tubules that show a loss of brush border, cell swelling, and vacuolization. A
distal (D) tubule also shows injury. An animal that received uranyl nitrate
and treatments with both CEI and PVE also showed injury to some
proximal (P) and distal (D) tubules. (x 100)
added to early proximal tubule segments was 96.0 2.7%, not different from 100% (NS), demonstrating no significant
when compared to control perfusions. This value of 96% was "backleak" along the accessible proximal tubule.
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Renal morphology
The morphology of the visceral epithelial cells of the renal
corpuscle appeared similar for all experimental conditions and
identical to the control state, as observed by transmission
electron microscopy.
Obvious cell injury in proximal, distal, and cortical collecting
tubules was observed in many nephrons, regardless of the
experimental condition (Figs. 2 and 3), The severity and distri-
bution of the injury was determined by a semiquantitative
histologic analysis to be similar for all protocols when com-
pared to controls (Table 3).
The injured cells were characterized by a loss of microvilli,
cell swelling, numerous vacuoles of various sizes, enlarged
lysosomes, and occasionally swollen mitochondria (Figs. 2 and
3). The cell injury was not localized to a particular segment of
the proximal tubules in that all segments (S1, S2, and S3) were
affected. Cast material was noted in the proximal distal collect-
ing tubules (Fig. 3).
The LpA was definitely decreased only in the group of rats
that received UN and no other treatments. The word, defi-
nitely, was used to signify that since filtration pressure equilib-
rium was not attained in rats receiving UN alone, in spite of the
lower values for nephron plasma flow, an exact value for LpA
could be defined (Table 1). In several of the other experimental
groups, filtration pressure equilibrium was attained and only a
minimum estimate of LpA could be defined. However, even
these values were significantly higher than the value in rats
receiving only UN (Fig. 1).
Discussion
A reduction in the glomerular ultrafiltration coefficient (LpA)
has been demonstrated to be a major factor contributing to the
decrease in glomerular filtration rate, which has been observed
in various experimental models of acute renal failure [1, 23, 24].
The nephrotoxic form of acute renal failure that results from the
administration of uranyl nitrate represents one of the earliest
direct demonstrations of a reduction in LpA [1, 25]. Since
uranyl nitrate produces significant renal cellular injury [1, 14,
15], it might be assumed that such alterations in LpA are
irreversible. However, the results of the present study demon-
strate this conclusion is not justified. Pretreatment of rats with
converting enzyme inhibitor and the combination of converting
enzyme inhibitor and plasma volume expansion results in
normalization of LpA and, in the latter case, of nephron
filtration rate.
The initial studies from this laboratory on the mechanism of
reductions in GFR after uranyl nitrate determined that both
tubular and glomerular events contributed to this process [1].
Inulin "backleak" was demonstrated as a consequence of
uranyl nitrate-induced late proximal tubular damage. The re-
duction in LpA could also have resulted from glomerular
accumulation of uranium, however, it has been impossible to
demonstrate uranium in glomerular structures [1, 15]. Morpho-
logic analysis in this study revealed equivalent degrees of
tubular damage in all groups that received UN, and physiologic
data suggested that the greater reduction in whole kidney C1
observed in rats receiving UN was likely the result of persistent
tubular inulin "backleak" beyond the accessible proximal
tubule, an element apparently unaffected by CEI and PVE [1].
Table 3. Semiquantitative histologic analysis of severity and
distribution of cell injury in proximal, distal, and collecting
tubules of control and experimental groups
Treatment
Proximal
tubules
Distal
tubules
Collecting
tubules
Control Oa 0 0
(N=5)
Uranyl nitrate (UN) 2,5b 30b 25"(N =5)
UN and CEI 25b 27b 25b(N=5)
UN and PVE 22b 30b 25b
(N =5)
UN and PVE + CEI 2.5" 25b 2.5"(N=5)
N, number of animals studied.
Values expressed as mean pathological score.
b Statistical significance was determined by two-way analysis of
variance. All experimental groups were statistically similar when com-
pared to the controls, P < 0.05.
A specific mechanism whereby tubular damage is linked to the
reductions in both nephron filtration rate and LpA has not been
defined in this model (tubular obstruction is minimal in this form
of acute renal failure). The physiologic results of this study do
suggest that the events at the glomerulus, the reduction in LpA,
can be functionally separated from the tubular damage resulting
from UN by treatments with either or both CEI and PVE.
CEI pretreatment in rats receiving UN was sufficient to restore
LpA to values indistinguishable from normal at filtration pressure
equilibrium, however, examination of the data in Table 1 reveals
that neither SNGFR nor whole kidney C111 was restored to normal
values in UN rats by CEI pretreatment alone. The SNGFR
remained lower than control because of a reduction in nephron
plasma flow (SNPF), which resulted from a decrease in mean
arterial pressure in rats receiving both CEI and UN and an
inadequate autoregulatory adjustment of afferent arteriolar resist-
ance. The lower MAP in this group of 83 mm Hg was undoubtedly
multifactorial, resulting from the urinary volume losses after UN,
documented in this study and our previous study Eli, and the
combined effects of CEI and UN on peripheral vascular resist-
ance. The continued subnormal value for whole kidney C111 was
due to the above effects on SNGFR and the documented trans-
epithelial backleak of solutes as large as inulin in areas of damaged
epithelium beyond the proximal tubule. We have demonstrated
previously that if inulin was microinjected into proximal tubules of
rats receiving UN, major losses of inulin occurred prior to the final
urine [1]. However, since nephron filtration rates collected in early
and late proximal tubular segments were not different, no signifi-
cant "backleak" of inulin was demonstrated across the accessible
surface proximal tubules. In the current analysis, when inulin-
containing solutions were perfused into early proximal tubule
segments of rats that received UN, recovery of inulin from late
proximal tubule segments was nearly 100%, in spite of the
apparent tubular damage. From the results of the current study, it
is clear that CEI pretreatment and PVE did not prevent either
tubular damage or back diffusion of inulin out of damaged tubules,
an important contribution to the final C1. It is clear, however, that
CEI did prevent the UN-induced reduction in LpA. CEI does not
increase LpA in the normal rat to supranormal values (Table 2).
In the other experimental groups receiving UN, PVE after
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Fig. 3. The appearance of proximal convoluted (left) and distal tubules (right) by transmission electron microscopy after 90 mm of uranyl nitrate
administration. The proximal tubule on the left demonstrates a loss of apical microvilli (arrow) and an enormous vacuole (V), which has displaced
the nucleus (N) and mitochondria. The distal tubular cells on the right exhibit numerous large vacuoles (V), suggesting cell injury. Cellular debris
(arrows) is also found within the tubular lumen, denoting cellular necrosis. Cellular injury of proximal and distal tubular cells was approximately
equal in all groups of rats that received uranyl nitrate, regardless of further treatment with CE!, PVE, and the combination of treatments. (X 3,000).
UN administration and the combination of PVE and CEI
pretreatment, LpA was also restored to values that should be
considered "normal" for the rat. SNGFR was restored in these
groups to at least the normal hydropenic control values (Table
1). This restoration of SNGFR to normal was in part the
consequence of a normalization of LpA, but also the result of a
maintenance of a more normal value for MAP and nephron
plasma flow. The fact that values for SNGFR remained lower
than values for SNGFR in rats submitted to PVE only, may be
the result of acute volume losses incurred by rats receiving UN,
a finding documented in this study and in our original study on
this issue [1]. Based upon the ratio of SNGFR to total kidney
GFR, one might conclude that PVE also reduced the degree of
inulin "backleak". Inulin "backleak" is not only a function of
the degree of tubular damage, but also a function of the
transtubular inulin concentration gradient, which would un-
doubtedly be lower in PVE than hydropenia, a factor which
exerted an apparently more beneficial effect on GFR in PVE
treated rats.
The physiologic results of this study imply a role for angio-
tensin II in the reduction in LpA that occurs after UN admin-
istration. Both converting enzyme inhibition and plasma vol-
ume expansion are likely to decrease intrarenal angiotensin II
activity [9, 10]. Angiotensin II has been demonstrated capable
of producing a reduction in LpA [3, 6, 8, 26]. Certain studies
have suggested that mesangial cell contraction in response to
angiotensin II may underlie this decrease in LpA [5]. Alterna-
tively, the physiologic effects of both CEI treatment and PVE
are multifactorial and may involve other processes that may
effect the apparent functional link between tubular damage and
glomerular dysfunction, that is, influences on tubuloglomerular
feedback mechanisms. Baylis and co-workers have demon-
strated that gentamicin administration in rats resulted in a
decrease in nephron filtration rate that was largely the result of
reductions in the glomerular ultrafiltration coefficient, Kf or
LpA [24]. In later studies from this same laboratory, Schor eta!
demonstrated that chronic pretreatment with an oral converting
enzyme inhibitor prevented the gentamicin-induced reductions
in LpA and nephron filtration rate [27]. The results of these
studies and the current investigation would suggest that reduc-
tions in intrarenal angiotensin II activity can lead to prevention
of the functional reduction in the glomerular ultrafiltration
coefficient in at least two separate and distinct forms of
nephrotoxic acute renal failure.
The issue of the role of angiotensin II in experimental acute
renal failure has undergone considerable revision since first
proposed as a basis for "vasomotor nephropathy" [28]. The
study on uranyl nitrate acute renal failure from this laboratory
was one of several studies that demonstrated that increased
renal vascular resistance and major reductions in nephron blood
flow were not necessary for the major reduction in glomerular
filtration rate in acute renal failure [1]. The results of this study
do suggest that prevention of renal angiotensin II generation
can provide major beneficial effects in a model of acute renal
failure without exerting an effect on nephron blood flow. To the
extent that reduced intrarenal All mediates the beneficial
effects of CE! and PVE, the effects of All must be localized to
the glomerular capillary and LpA. A reasonable explanation for
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the apparently selective glomerular capillary effects of angio-
tensin II is that uranium may prevent the renal vascular
response at the arteriolar resistance vessels. This speculation is
supported by the apparent lack of renal autoregulatory vasodi-
lation in response to reductions in blood pressure in rats
receiving UN (Table 1). Although morphologic changes within
the glomerulus have been reported after UN [29], there is no
evidence that All influences glomerular endothelial cells.
A reasonable explanation for the functional link between
tubular damage and alterations in glomerular function involves
the tubuloglomerular feedback mechanism. Tubular damage
alter UN probably decreases transport of NaC1 and water in the
proximal nephron. Increases in the rate of delivery of tubular
fluid and NaC1 to the distal nephron results in reduction in
nephron filtration rate and may alter All generation [30].
Studies from several laboratories have shown that these feed-
back-induced changes in SNGFR are due to changes in vascular
resistances, resulting in alterations in nephron plasma flow and
glomerular capillary pressure [31, 32] and, in certain circum-
stances, alterations in LpA or Kf [331. To an extent, suppres-
sion of angiotensin II activity does inhibit the full or normal
expression of tubuloglomerular feedback activity [32, 34, 35J.
As noted previously, CEI and PVE suppress both angiotensin II
and tubuloglomerular feedback activity, such that the tubulo-
glomerular feedback mechanism remains a potential explana-
tion linking tubular damage to the functional alteration in
nephron filtration rate and LpA. However, such treatments
may also alter basal activity of other systems, such as renal
adrenergic activity and prostaglandin generation.
Cage studies on the effects of CEI in rats receiving UN were
of interest. As observed in our prior study, most rats receiving
UN developed oliguria within 2 to 3 days after administration of
UN and several died within 5 days. CEI treatment largely
prevented the development of oliguria, probably by maintaining
SNGFR in the face of major tubular damage. In fact, rats
receiving UN and CE! became significantly volume depleted as
indexed by an acute reduction in body wt of 18%. CE! did not
prevent death alter UN but, in all probability, these animals
died, in part, as a result of volume depletion.
The current study demonstrates that the reduction in glomer-
ular ultrafiltration coefficient (LpA) alter uranyl nitrate is func-
tional in nature in that changes can be largely prevented by
prior administration of angiotensin converting enzyme inhibitor
and normalized by plasma volume expansion and a combination
of these two treatments. These functional glomerular changes
occurred in spite of equivalent degrees of tubular damage
observed in all experimental groups receiving uranyl nitrate.
Results are compatible with the hypothesis that glomerular
alterations may be due either to the intrarenal generation of
angiotensin II or the activation of the tubuloglomerular feed-
back mechanism.
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